Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany
Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.
BMJ Open. 2021 Nov 2;11(11):e052004. doi: 10.1136/bmjopen-2021-052004.
European guidelines recommended a uniform upper reference limit of high-sensitivity cardiac troponin T (hsTnT) to rule out non-ST segment elevation myocardial infarction. Our study aimed to provide a hsTnT reference distribution and to assess the specificity of the 14 ng/L cut-off value in the mobile population ≥70 years of age.
A cross-sectional analysis was performed in the German AugUR study (ltersbezogene ntersuchungen zur esundheit der niversity of egensburg).
Study population was the mobile population aged 70+ years living in the city and county of Regensburg, Germany.
A random sample was derived from the local population registries of residence. Of the 5644 individuals invited, 1133 participated (response ratio=20.1%). All participants came to the study centre and were mentally and physically mobile to conduct the protocol (face-to-face interview, blood draw and standardised transthoracic echocardiography). None of the participants was in an acute state of myocardial infarction.
Among the 1129 individuals with hsTnT measurements (overall median=10.0 ng/L(25th, 75th percentile)=(7.0, 15.0 ng/L)), hsTnT was higher among the older individuals and higher among men (men 70-74 years median=9.6 ng/L (7.2, 13.1 ng/L); men 90-95 years median=21.2 ng/L (14.6, 26.0 ng/L); women 70-74 years median=6.3 ng/L (4.7, 8.7 ng/L); and women 90-95 years median=18.0 ng/L (11.0, 21.0 ng/L)). In participants with impaired kidney function (eGFR <60 mL/min/1.73 m), hsTnT was elevated (median=13.6 ng/L (9.4, 20.6 ng/L)).Specificity of recommended upper reference limit, 14 ng/L, is 68%. Most false positives were among men aged >79 years (specificity=34%). In a healthy subgroup (n=96, none of the following: overt heart disease, impaired renal function, blood pressure >160/100 mm Hg, left ventricular hypertrophy and diastolic/systolic dysfunction), specificity was 90%.
In the elderly population without acute myocardial infarction, hsTnT further increases with age showing different levels for men and women. The specificity of the 14 ng/L cut-off is considerably lower than 99%, even in healthy subjects.
欧洲指南建议采用统一的高敏心肌肌钙蛋白 T(hsTnT)上限参考值来排除非 ST 段抬高型心肌梗死。本研究旨在提供 hsTnT 参考分布,并评估 14ng/L 截断值在≥70 岁的流动人群中的特异性。
德国 AugUR 研究(ltersbezogene ntersuchungen zur esundheit der niversity of egensburg)进行了一项横断面分析。
研究人群为居住在德国雷根斯堡市和郡的 70 岁及以上的流动人群。
从当地居民登记处抽取随机样本。在邀请的 5644 名参与者中,有 1133 名(应答率=20.1%)参加了研究。所有参与者均来到研究中心,且精神和身体状况均适合进行方案(面对面访谈、采血和标准经胸超声心动图)。无参与者处于急性心肌梗死状态。
在有 hsTnT 测量值的 1129 名个体中(总体中位数=10.0ng/L(25 百分位,75 百分位)=(7.0,15.0ng/L)),hsTnT 随年龄增长而升高,且男性高于女性(70-74 岁男性中位数=9.6ng/L(7.2,13.1ng/L);90-95 岁男性中位数=21.2ng/L(14.6,26.0ng/L);70-74 岁女性中位数=6.3ng/L(4.7,8.7ng/L);90-95 岁女性中位数=18.0ng/L(11.0,21.0ng/L))。在肾功能受损(eGFR<60mL/min/1.73m2)的参与者中,hsTnT 升高(中位数=13.6ng/L(9.4,20.6ng/L))。建议的上限参考值 14ng/L 的特异性为 68%。大多数假阳性出现在>79 岁的男性中(特异性=34%)。在一个健康亚组(n=96,以下均无:明显心脏病、肾功能受损、血压>160/100mmHg、左心室肥厚和舒张/收缩功能障碍)中,特异性为 90%。
在无急性心肌梗死的老年人群中,hsTnT 随年龄进一步增加,男性和女性的水平不同。14ng/L 截断值的特异性明显低于 99%,即使在健康受试者中也是如此。